Autoantibodies to MUC1 glycopeptides cannot be used as a screening assay for early detection of breast, ovarian, lung or pancreatic cancer

BACKGROUND: Autoantibodies have been detected in sera before diagnosis of cancer leading to interest in their potential as screening/early detection biomarkers. As we have found autoantibodies to MUC1 glycopeptides to be elevated in early-stage breast cancer patients, in this study we analysed these...

Descripción completa

Detalles Bibliográficos
Autores principales: Burford, B, Gentry-Maharaj, A, Graham, R, Allen, D, Pedersen, J W, Nudelman, A S, Blixt, O, Fourkala, E O, Bueti, D, Dawnay, A, Ford, J, Desai, R, David, L, Trinder, P, Acres, B, Schwientek, T, Gammerman, A, Reis, C A, Silva, L, Osório, H, Hallett, R, Wandall, H H, Mandel, U, Hollingsworth, M A, Jacobs, I, Fentiman, I, Clausen, H, Taylor-Papadimitriou, J, Menon, U, Burchell, J M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2013
Materias:
Molecular Diagnostics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3670483/
https://www.ncbi.nlm.nih.gov/pubmed/23652307
http://dx.doi.org/10.1038/bjc.2013.214

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3670483/
https://www.ncbi.nlm.nih.gov/pubmed/23652307
http://dx.doi.org/10.1038/bjc.2013.214

Ejemplares similares